Omri Nativ
Papers
2
Total Citations
106
H-Index
2
About
Omri Nativ is a leading urologic researcher whose work centers on improving the accuracy of prostate cancer diagnosis and advancing surgical techniques for renal masses. His most impactful contribution addresses the critical challenge of overdiagnosis in prostate cancer. In his highly cited 2020 study (103 citations), Nativ demonstrated that incorporating prostate volume into PSA density calculations significantly improves the stratification of patients with clinically significant prostate cancer. This work provides a practical, non-invasive tool to help reduce unnecessary biopsies and overtreatment, directly impacting clinical decision-making. Beyond diagnostics, Nativ has contributed to surgical innovation, notably investigating the safety and efficacy of biological glues like Starsil® Hemostat to control bleeding during robotic partial nephrectomy—a key complication in nephron-sparing surgery for small renal tumors. By combining rigorous outcomes research with a focus on operative challenges, Nativ’s work bridges the gap between early detection and safer surgical management, offering tangible improvements in patient care and surgical precision.
Research Focus
Key Achievements
Top Papers
- 1
- 2